This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Martin Donohoe, MD
Oregon Health Sciences University Portland

JAMA. 1997;278(11):896-897.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The article by Dr Dong and colleagues¹ highlights the nature of the problem of scientists' withholding data from colleagues and from peer-reviewed journals; Dr Rennie's Editorial² touches on the possible sequelae of such limitations on the free exchange of scientific information involving pharmaceutical and biotechnology-related research. I am concerned about similar problems limiting the nature, scope, and dissemination of results in health services research.

With the increasing enrollment of patients in managed care organizations (MCOs), coupled with cuts in government funding of organizations concerned with studying the processes and clinical outcomes of various models of clinical care for different diseases, more and more MCOs are funding internal outcome studies. Ideally, the goals of such research should be to study the effects of different clinical interventions on morbidity, mortality, and quality of life and to develop protocols for achieving enhanced outcomes at reduced cost. However, these organizations are increasingly . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?